枪支相关眼外伤出院去向差异分析
该回顾性分析利用2008至2014年美国国家创伤数据库(NTDB)中900余家机构的住院创伤病例,纳入8715例枪支相关眼外伤(FAOI)患者。研究发现,住院≥6天、年龄≥65岁、合并创伤性脑损伤、损伤严重度评分极高及白种人与出院转至高级护理机构(ACF)的较高 odds 相关,提示出院去向可能存在差异。
要点
- 8715例枪支伤累及眼,占全部枪支伤的3.7%。
- 出院去向:回家48.8%,转ACF 20.5%。
- 住院≥6天、≥65岁、合并TBI及极高ISS与转ACF较高 odds 相关。
核心结论
- 研究提示,年龄较大、损伤更重、持Medicare保险或白种人患者转至ACF的 odds 高于较年轻、损伤较轻、其他保险及黑人和西班牙裔患者。
- 作者指出,FAOI后出院去向可能存在差异,或限制特定人群的康复潜力。
研究设计与样本
- 回顾性分析美国国家创伤数据库(NTDB)2008年至2014年数据,覆盖900余家美国机构的住院创伤病例。
- 纳入因眼损伤住院的患者,采用ICD-9-CM诊断码和E码识别FAOI。
- 统计分析于2017年4月16日至2021年12月15日进行。
主要发现
- 235254例枪支伤中8715例累及眼(3.7%)。
- 8715例中男性7469例(85.7%),非洲裔3050例(35.0%),白种人4065例(46.6%),平均(SD)年龄33.8(16.9)岁。
- 常见支付方式:政府保险31.5%、自费29.4%、商业保险22.8%。
- 常见出院去向:回家48.8%、ACF 20.5%。
- 多变量分析中,转ACF的 odds 最高因素包括住院≥6天(OR 3.05;95%CI 2.56-3.63;P<.001)、年龄≥65岁(OR 2.94;95%CI 1.94-4.48;P<.001)、合并创伤性脑损伤(OR 2.32;95%CI 1.94-2.78;P<.001)、严重创伤性脑损伤(OR 2.10;95%CI 1.79-2.46;P<.001)及极重度损伤严重度评分(OR 2.22;95%CI 1.88-2.62;P<.001)。
关键数值与推荐
- 白种人与转ACF较高 odds 相关(OR 2.00;95%CI 1.71-2.33;P<.001)。
- Medicare保险与转ACF较高 odds 相关(OR 1.64;95%CI 1.16-2.31;P=.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究为回顾性性质。
- 研究团队无法探究这些出院去向差异的原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Firearm injuries are associated with devastating visual outcomes. Several studies have demonstrated disparities in trauma care and discharge to rehabilitation and other advanced care facilities (ACFs) due to race and ethnicity and insurance status. The identification of possible disparities in disposition of patients admitted with firearms-associated ocular injuries (FAOIs) is a crucial step in moving toward health equity. OBJECTIVE: To describe disposition patterns following admission for FAOI trauma. DESIGN, SETTING, AND PARTICIPANTS: This retrospective analysis of National Trauma Data Bank (NTDB) from 2008 through 2014 used hospitalized trauma cases from over 900 US facilities detailed in the NTDB. Participants included patients admitted with ocular injuries. Statistical analysis was conducted between April 16, 2017, and December 15, 2021. EXPOSURE: Firearm injuries. MAIN OUTCOMES AND MEASURES: Patients admitted with FAOIs were identified using International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic codes and E-codes. Demographic data, location, injury type and severity, and insurance status were documented. The primary outcome was the odds of discharge to ACFs. RESULTS: A total of 8715 of 235 254 firearms injuries involved the eye (3.7%). Of the 8715 included patients, 7469 were male (85.7%), 3050 were African American (35.0%), and 4065 White (46.6%), with a mean (SD) age of 33.8 (16.9) years. Common payments were government insurance (31.5%), self-paid insurance (29.4%), and commercial insurance plans (22.8%). Frequent dispositions were home (48.8%) and ACF (20.5%). Multivariate analysis demonstrated that the following factors were associated with the highest odds of discharge to an ACF: hospital stays 6 days or longer (odds ratio [OR], 3.05; 95% CI, 2.56-3.63; P < .001), age 65 years or older (OR, 2.94; 95% CI, 1.94-4.48; P < .001), associated traumatic brain injury (OR, 2.32; 95% CI, 1.94-2.78; P < .001), severe traumatic brain injury (OR, 2.10; 95% CI, 1.79-2.46; P < .001), and very severe Injury Severity Score (OR, 2.22; 95% CI, 1.88-2.62; P < .001). White race (OR, 2.00; 95% CI, 1.71-2.33; P < .001) was associated with higher odds than Medicare insurance (OR, 1.64; 95% CI, 1.16-2.31; P = .01). CONCLUSIONS AND RELEVANCE: These findings suggest that older, more severely injured, Medicare-insured, or White patients have higher odds of ACF placement than younger, less severely injured, otherwise insured, and Black and Hispanic patients. This study is limited by its retrospective nature and the study team was unable to explore the basis for these disposition differences. Nevertheless, this work highlights that disparities may exist in disposition after FAOIs that may limit the rehabilitation potential of specific populations.
引用
- Mike EV, Brandsdorfer A, Parsikia A, et al. Disparities Associated with Discharge Patterns in Firearm-Associated Ocular Trauma. JAMA Ophthalmol. 2023. PMID: 37166790. doi:10.1001/jamaophthalmol.2023.1467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。